These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16454829)

  • 1. Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.
    Thomas-Marques L; Murat A; Delemer B; Penfornis A; Cardot-Bauters C; Baudin E; Niccoli-Sire P; Levoir D; Choplin Hdu B; Chabre O; Jovenin N; Cadiot G;
    Am J Gastroenterol; 2006 Feb; 101(2):266-73. PubMed ID: 16454829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of imaging procedures for the detection of pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.
    Langer P; Kann PH; Fendrich V; Richter G; Diehl S; Rothmund M; Bartsch DK
    World J Surg; 2004 Dec; 28(12):1317-22. PubMed ID: 15517479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural course of small, asymptomatic neuroendocrine pancreatic tumours in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study.
    Kann PH; Balakina E; Ivan D; Bartsch DK; Meyer S; Klose KJ; Behr T; Langer P
    Endocr Relat Cancer; 2006 Dec; 13(4):1195-202. PubMed ID: 17158764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic ultrasonography for evaluation of pancreatic tumours in multiple endocrine neoplasia type 1.
    Hellman P; Hennings J; Akerström G; Skogseid B
    Br J Surg; 2005 Dec; 92(12):1508-12. PubMed ID: 16231278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective controlled trial of a standardized meal stimulation test in the detection of pancreaticoduodenal endocrine tumours in patients with multiple endocrine neoplasia type 1.
    Langer P; Wild A; Celik I; Kopp I; Bergenfelz A; Bartsch DK
    Br J Surg; 2001 Oct; 88(10):1403-7. PubMed ID: 11578300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EUS detection of pancreatic endocrine tumors in asymptomatic patients with type 1 multiple endocrine neoplasia.
    Wamsteker EJ; Gauger PG; Thompson NW; Scheiman JM
    Gastrointest Endosc; 2003 Oct; 58(4):531-5. PubMed ID: 14520285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ≤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d'Etude des Tumeurs Endocrines.
    Triponez F; Sadowski SM; Pattou F; Cardot-Bauters C; Mirallié E; Le Bras M; Sebag F; Niccoli P; Deguelte S; Cadiot G; Poncet G; Lifante JC; Borson-Chazot F; Chaffanjon P; Chabre O; Menegaux F; Baudin E; Ruszniewski P; Du Boullay H; Goudet P
    Ann Surg; 2018 Jul; 268(1):158-164. PubMed ID: 28263205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of asymptomatic pancreatic neuroendocrine tumors in multiple endocrine neoplasia type I syndrome.
    Dʼsouza SL; Elmunzer BJ; Scheiman JM
    J Clin Gastroenterol; 2014; 48(5):458-61. PubMed ID: 24356459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endoscopic ultrasonography in screening and treatment of pancreatic endocrine tumours in asymptomatic patients with multiple endocrine neoplasia type 1.
    Gauger PG; Scheiman JM; Wamsteker EJ; Richards ML; Doherty GM; Thompson NW
    Br J Surg; 2003 Jun; 90(6):748-54. PubMed ID: 12808627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.
    Gonçalves TD; Toledo RA; Sekiya T; Matuguma SE; Maluf Filho F; Rocha MS; Siqueira SA; Glezer A; Bronstein MD; Pereira MA; Jureidini R; Bacchella T; Machado MC; Toledo SP; Lourenço DM
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E89-96. PubMed ID: 24178797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is surgery beneficial for MEN1 patients with small (< or = 2 cm), nonfunctioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from the GTE.
    Triponez F; Goudet P; Dosseh D; Cougard P; Bauters C; Murat A; Cadiot G; Niccoli-Sire P; Calender A; Proye CA;
    World J Surg; 2006 May; 30(5):654-62; discussion 663-4. PubMed ID: 16680582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative Imaging Overestimates the Tumor Size in Pancreatic Neuroendocrine Neoplasms Associated with Multiple Endocrine Neoplasia Type 1.
    Polenta V; Slater EP; Kann PH; Albers MB; Manoharan J; Ramaswamy A; Mahnken AH; Bartsch DK
    World J Surg; 2018 May; 42(5):1440-1447. PubMed ID: 29075857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth rate of small pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: results from an endoscopic ultrasound based cohort study.
    Kappelle WF; Valk GD; Leenders M; Moons LM; Bogte A; Siersema PD; Vleggaar FP
    Endoscopy; 2017 Jan; 49(1):27-34. PubMed ID: 27975336
    [No Abstract]   [Full Text] [Related]  

  • 14. EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1.
    van Asselt SJ; Brouwers AH; van Dullemen HM; van der Jagt EJ; Bongaerts AH; Kema IP; Koopmans KP; Valk GD; Timmers HJ; de Herder WW; Feelders RA; Fockens P; Sluiter WJ; de Vries EG; Links TP
    Gastrointest Endosc; 2015 Jan; 81(1):159-167.e2. PubMed ID: 25527055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of pancreaticoduodenal endocrine tumours in patients with MEN 1: multidetector-row computed tomography vs. endoscopic ultrasound.
    Camera L; Paoletta S; Mollica C; Milone F; Napolitano V; De Luca L; Faggiano A; Colao A; Salvatore M
    Radiol Med; 2011 Jun; 116(4):595-606. PubMed ID: 21286942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging versus endoscopic ultrasonography for the detection of pancreatic tumours in multiple endocrine neoplasia type 1.
    Barbe C; Murat A; Dupas B; Ruszniewski P; Tabarin A; Vullierme MP; Penfornis A; Rohmer V; Baudin E; Le Rhun M; Gaye D; Marcus C; Cadiot G;
    Dig Liver Dis; 2012 Mar; 44(3):228-34. PubMed ID: 22078814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance?
    Bartsch DK; Langer P; Wild A; Schilling T; Celik I; Rothmund M; Nies C
    Surgery; 2000 Dec; 128(6):958-66. PubMed ID: 11114630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presentation and outcome of pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1 syndrome.
    Davì MV; Boninsegna L; Dalle Carbonare L; Toaiari M; Capelli P; Scarpa A; Francia G; Falconi M
    Neuroendocrinology; 2011; 94(1):58-65. PubMed ID: 21464564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients.
    Qiu W; Christakis I; Silva A; Bassett RL; Cao L; Meng QH; Gardner Grubbs E; Zhao H; Yao JC; Lee JE; Perrier ND
    Clin Endocrinol (Oxf); 2016 Sep; 85(3):400-7. PubMed ID: 27256431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low accuracy of tumor markers for diagnosing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 patients.
    de Laat JM; Pieterman CR; Weijmans M; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Vriens MR; Valk GD
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4143-51. PubMed ID: 23956349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.